BIOAGE LABS INC (BIOA) Stock Income Statement
NASDAQ:BIOA - US09077V1008 - Common Stock
4.71 USD
-0.03 (-0.63%)
4.61 USD
-0.1 (-2.12%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 3.86M | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 95.19M | 78.19M | 48.40M | 39.97M | |||
| Research and Development | 70.20M | 59.04M | 33.89M | 30.52M | |||
| Selling, General, and Administrative Expenses | 25.00M | 19.16M | 14.51M | 9.45M | |||
| Operating Income | -91.33M | -78.19M | -48.40M | -39.97M | |||
| Interest Income/Expense | 12.10M | 7.26M | -5.36M | 224.00K | |||
| Other Income/Expense | 199.00K | 73.00K | -10.09M | 23.00K | |||
| Non Recurring Items | N/A | -250.00K | N/A | N/A | |||
| Income Before Taxes | -79.03M | -71.11M | -63.85M | -39.72M | |||
| Net Income | -79.03M | -71.11M | -63.85M | -39.72M | |||
| EBITDA | -91.15M | -78.03M | -48.24M | -39.84M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -2.16 | -1.98 | -1.87 | -1.16 | |||
| Non GAAP EPS | -9.63 | N/A | N/A | N/A | |||
| Statistics | |||||||
| Profit Margin | -2045.74% | N/A | N/A | N/A | |||
| Operating Profit Margin | -2364.20% | N/A | N/A | N/A | |||
All data in USD